Therapeutic Asset Ratings
3,187 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
cht101
Metastatic Neoplasm
Zhejiang University
P1
CC
(43)
cht101
Non-Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and Hospital
P1
CC
(43)
Ciml-Nk Cells
Juvenile Myelomonocytic Leukemia
Dana-Farber Cancer Institute
P1
CC
(43)
Ciml-Nk Cell Therapy
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Claudin 18.2 Car-T
Ovarian Carcinoma
Suzhou Immunofoco Biotechnology Co., Ltd
P1
CC
(43)
Claudin18.2-Targeted Car-Dcs
Colorectal Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
Claudin18.2-Targeted Car-T Cells
Colorectal Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
Clostridium Novyi-Nt
Breast Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Digestive System Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Female Reproductive Organ Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Head And Neck Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Male Reproductive Organ Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Malignant Mesothelioma
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Malignant Endocrine Neoplasm
M.D. Anderson Cancer Center
P1
CC
(43)
Cord Blood-Derived Expanded Allogeneic Natural Killer Cells
Gliosarcoma
M.D. Anderson Cancer Center
P1
CC
(43)
Cord Blood-Derived Expanded Allogeneic Natural Killer Cells
Glioblastoma
M.D. Anderson Cancer Center
P1
CC
(43)
Crte7A2-01 Tcr-T Cell
Head And Neck Cancer
Corregene Biotechnology Co., Ltd
P1
CC
(43)
Crte7A2-01 Tcr-T Cell Therapy
Head And Neck Cancer
Corregene Biotechnology Co., Ltd
P1
CC
(43)
Cryopreserved Be Car33 T Cells
Acute Myeloid Leukemia
Great Ormond Street Hospital for Children NHS Foundation Trust
P1
CC
(43)
ct-0525
HER2 Positive Breast Carcinoma
Carisma Therapeutics Inc
P1
CC
(43)
Cxcr4 Ccr9 Car-T
T Lymphoblastic Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University
P1
CC
(43)
cy-219 car-t
Indolent B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P1
CC
(43)
cy-219 car-t
B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P1
CC
(43)
Cyad-101
Colorectal Cancer
Celyad Oncology SA
P1
CC
(43)
Cytokine-Induced Memory-Like Natural Killer Cells
Ovarian Clear Cell Adenocarcinoma
Dana-Farber Cancer Institute
P1
CC
(43)
Showing 1301 to 1325 of 3,187 assets
Previous
Page 53 of 128
Next
